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Abstract
D-dopachrome tautomerase (D-DT/MIF-2) is a member of the macrophage migration inhibitory factor (MIF) cytokine superfamily, and a close
structural homolog of MIF. MIF and D-DT have been reported to be involved in obesity, but there is little known about the regulation of D-DT in
adipose tissue inflammation and wound healing. Subcutaneous adipose tissue was collected from 54 healthy donors and 28 donors with acutely
inflamed wounds undergoing wound debridement. In addition, epididymal fat pads of mice were injected with lipopolysaccharide to study recep-
tor expression and cell migration in vivo. D-DT protein levels and mRNA expression were significantly decreased in subcutaneous adipose tis-
sue adjacent to acutely inflamed wounds. D-DT improved fibroblast viability and increased proliferation in vitro. While D-DT alone did not have
a significant effect on in vitro fibroblast wound healing, simultaneous addition of neutralizing MIF antibody resulted in a significant improvement
of fibroblast wound healing. Interestingly, expression of the MIF and D-DT receptor CD74 was down-regulated while the MIF receptors CXCR2
and CXCR4 were up-regulated primarily on macrophages indicating that the MIF-CXCR2/4 axis may promote recruitment of inflammatory cells
into adipose tissue. Our results describe a reciprocal role of D-DT to MIF in inflamed adipose tissue, and indicate that D-DT may be beneficial in
wound repair by improving fibroblast survival and proliferation.
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Introduction
Wound repair is a complex response by the host to tissue damage,
and wound healing disorders contribute to significant morbidity and
excess health care expenditures [1]. Acute wound healing disorders
occur at areas of adipose tissue inflammation [2, 3], which can
lead to life-threatening complications and extended soft tissue
defects requiring complex reconstruction procedures [4]. In the
past several years, adipose tissue has been determined to be an
important endocrine organ that orchestrates diverse responses by
the release of specialized cytokines in an autocrine and paracrine
manner [5]. Subcutaneous adipose tissue contributes to cutaneous
wound healing through the secretion of adipokines and the differen-
tiation of progenitor cells into keratinocytes and fibroblasts [6–10].
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Obesity has been implicated in a number of autoimmune diseases
and the increasing number of obese patients with impaired wound
healing has generated significant interest in the function of adipoki-
nes during wound repair [9]. One adipokine that has been recently
characterized in obesity and insulin resistance is D-dopachrome
tautomerase (D-DT) [11]. D-DT was first described by Odh and col-
leagues as an enzyme in human melanoma, human liver and sev-
eral rat organs which tautomerizes D-dopachrome, but its precise
role in body physiology remained unknown for many years [12].
The description of structural and functional similarities between D-
DT and the innate cytokine macrophage migration inhibitory factor
(MIF) recently advanced our understanding of D-DT significantly
[13,14] and led to the alternative designation of D-DT as MIF-2
[15].
We previously reported increased MIF levels in subcutaneous adi-
pose tissue in participants with acute wound healing disorders and
proposed that MIF may mediate the recruitment of inflammatory cells
[4]. While MIF and D-DT share functional similarities, expression data
suggest that during chronic adipose tissue inflammation and obesity,
the two cytokines have opposing or complementary roles [11]. Migra-
tion inhibitory factor promotes chronic adipose tissue inflammation
and its expression positively correlates with obesity and insulin resis-
tance, whereas D-DT expression shows a negative correlation [11,
16]. The goal of this study was to elucidate more precisely the func-




Healthy adipose tissue (HAT) was collected from healthy patients
undergoing elective plastic surgery, whereas inflammatory adipose tis-
sue (IAT) was harvested from acute wound healing disorders. Those
were defined as wounds caused by external trauma, iatrogenic manipu-
lation and surgical intervention, which were not resolved within a period
of 4 weeks after trauma [2,3]. All cases showed classic signs of local
inflammation (tumour, calor, rubor, dolour and functio laesa) and had
negative bacterial swab samples at the time of tissue harvest. The adi-
pose tissue was excised and sample preparation was carried out as
previously described [4]. All surgeries were performed in the Depart-
ment of Plastic Surgery, Hand Surgery – Burn Center of the RWTH
University Hospital Aachen, Germany. The study was approved by the
ethics committee of the RWTH Aachen University (EK 163/07), with
written informed consent provided by patients or relatives. All experi-
ments were performed in compliance with the Declaration of Helsinki
Principles.
Tissue homogenization and detection of total
protein
Whole adipose tissue samples were homogenized as described earlier
[17]. Total protein content of whole adipose tissue samples was
measured by the DC Protein Assay (Bio-Rad Laboratories GmBH,
Munich, Germany) according to the manufacturer’s instructions.
Human and murine D-DT Enzyme linked
immunosorbent assay (ELISA)
D-dopachrome tautomerase protein levels of human adipose tissue
homogenates and murine epididymal fat pads were measured by ELISA
as previously reported [13].
Real-time PCR
Messenger RNA from human adipose tissue and murine epididymal fat
pads was extracted by the RNeasy Mini Kit (Qiagen NV, Venlo, The
Netherlands) and cDNA synthesis was performed with the QuantiTect
Reverse Transcription Kit (Qiagen Inc., Valencia, CA, USA) following the
manufacturer’s instructions. Complementary DNA was subject to quanti-
tative real-time (RT) PCR using the SYBR Green Master Mix (Bio-Rad
Laboratories, Inc., Hercules, CA, USA). Primers used in this study are
listed in Table S1. For human samples, GAPDH was used as an internal
control, while in mice b-actin served as a reference. Data were analysed
with the comparative cycle time (CT) method.
Immunohistochemical staining for D-DT, CXCR2,
CXCR4 and CD74
Paraffin embedded whole adipose tissue samples were sectioned and
stained with haematoxylin/eosin and 3,30-Diaminobenzidine (Invitrogen,
Thermo Fisher Scientific, MA, USA). Polyclonal rabbit anti-human D-DT
antibody [13], CD74 (Invitrogen, Thermo Fisher Scientific, Waltham,
Massachusetts, United States), anti-human CXCR2 and CXCR4 (both
Abcam, Cambridge, UK) were used for immunohistochemical staining.
Istoype controls served as negative control, testis and bone marrow
served as positive controls.
CXCR2, CXCR4 and CD74 staining by flow
cytometry
Adipocytes and adipose tissue macrophages (ATM) were isolated from
lipopolysaccharide (LPS) or PBS-injected mice for flow cytometry by
collagenase digestion as previously described [18,19]. Used antibodies
are found in Table S2. ATMs were stained for CD45, CD11b and F4/80.
Adipocytes were stained for CR4. Fluorescence minus one controls were
included for both cell types. Samples were measured on a LSR flow
cytometer (BD Bioscience, San Jose, CA, USA) and the data were anal-
ysed using FlowJo (FlowJo LLC, Ashland, OR, USA).
Isolation of human dermal fibroblasts
Human dermal fibroblasts (HDF) were isolated from healthy patients as
described earlier [20] and cultured at 37°C in a humidified atmosphere
at 5% CO2.
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Measurement of cell viability by the
alamarBlue assay
Viability of HDF was measured by the alamarBlue assay (Invitrogen,
Thermo Fisher Scientific, Darmstadt, Germany) according to the man-
ufacturer’s guidelines. Human dermal fibroblasts were seeded in 96
well plates. The following day, alamarBlue reagent was added to
untreated HDF, this time-point is referred to as the baseline viability.
All wells were washed and incubated with supernatants from HAT
and IAT, supplemented with varying concentrations of recombinant
human D-DT. After 24 hrs, another alamarBlue measurement was
performed.
Measurement of cell proliferation by the
bromodeoxyuridine ELISA
Proliferation of HDF was analysed by the CytoSelectTM bromod-
eoxyuridine (BrdU) Cell Proliferation Elisa Kit (Cell Biolabs Inc., San
Diego, CA, USA). Human dermal fibroblasts were seeded in 96 well
plates. The following day, cells incubated with supernatants from HAT
and IAT, supplemented with varying concentrations of recombinant
human D-DT for 24 hrs. BrdU incorporation was measured according to
the manufacturer’s instructions.
In vitro wound healing assay
In vitro wound healing was performed by a standard in vitro wound
healing assay [21]. Briefly, HDF monolayers were scratched by a 200 ll
pipette tip. Medium containing 10% FCS served as a positive control,
while medium containing 0.5% FCS served as a negative control.
Human dermal fibroblasts were incubated with supernatants for 16 hrs,
which were supplemented with different concentrations of recombinant
human D-DT. 10 lg/ml Mitomycin C (Sigma Aldrich Chemie GmbH,
Taufkirchen, Germany) was utilized to examine proliferation and migra-
tion-related wound healing. The MIF antibody III.D.9 was used to show
MIF-dependent effects as reported earlier [22]. Photographs were
acquired at 0 and 16 hrs after the scratch. The migration (addition of
Mitomycin C) and migration/proliferation distance (absence of Mito-
mycin C) were deduced by comparing the 0 and 16 hrs photographs by
the Software Photoshop CS5 (Adobe Systems, Mountain View, CA,
USA).
In vivo macrophage migration model
In vivo macrophage migration into epididymal fat pads of mice was per-
formed as published earlier [4,23]. Ten-week-old male C57BL/6 wild-
type (WT) mice purchased from Charles River Laboratory (Wilmington,
DE, USA) were used. All mice were fed with standard chow and water
Fig. 1 Levels of D-DT in native HAT and IAT. Adipose tissue from healthy donor sites and acutely inflamed donor sites were homogenized. D-DT
protein levels were analysed by ELISA and D-DT mRNA levels were measured by quantitative real-time PCR. (A) D-DT protein levels were signifi-
cantly decreased in IAT compared to native HAT. Data are presented as mean  S.E.M., n = 54–28, two-tailed Student’s t-test. (B) Relative D-DT
expression levels in adipose tissue derived from HAT and IAT showed a decrease of D-DT expression in IAT. Data are presented as mean  S.E.M.,
n = 13–16, two-tailed Student’s t-test. Statistically significant differences are indicated by asterisks (*P < 0.05, **P < 0.01). D-DT expression was
analysed by immunohistochemistry on formalin fixed whole adipose tissue of (C) HAT and (D) IAT samples (magnification 400 9 ). Shown are rep-
resentative pictures of D-DT staining.
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ad libitum and experiments were approved by Yale University’s Institu-
tional Animal Care and Use Committee (2015-10756). Five mg/kg LPS
(Sigma-Aldrich, St. Louis, MO, USA) only, LPS together with either
20 lg mouse D-DT or the equal amount of mouse MIF was injected
into the epididymal fat pads via a small incision to induce local adipose
tissue inflammation. Control mice were treated with the equal volume of
PBS. Thioglycollate elicited peritoneal macrophages (PM) were labelled
with Cell Tracker Green CMFDA (Cell Tracker Green CMFDA Dye; Life
Technologies, Carlsbad, CA, USA). Next, labelled PMs were injected
retro-orbitally. Mice were killed after 48 hrs and epididymal fat tissue
was harvested, and the stromal vascular fraction (SVF) was isolated.
The isolated ATM were stained with Cd11b AlexaFluor700 (eBioscience,
San Diego, CA, USA), F4/80 eFluor450 (eBioscience) and Cd45 APC
(Biolegend, San Diego, CA, USA) as reported earlier [4].
Statistical analysis
For all statistical analysis and diagrams, the software GraphPad
Prism (GraphPad Software, Inc., La Jolla, CA, USA) was used. Data
were expressed as mean  S.E.M. After testing for normal distribution
using the Shapiro–Wilk-W-test, statistical differences between groups
were calculated by one-way ANOVA in case of three or more variables
and t-test in case of two variables. Post hoc testing was performed




Healthy adipose tissue samples were obtained from 54 patients [23
male and 31 female, mean age: 46.65  2.16 years, mean body
mass index (BMI): 30.03  1.065; Table S3]. Inflammatory adipose
tissue was obtained from 28 patients (15 male and 13 female, mean
age: 52.75  3.29 years, mean BMI: 30.81  2.634) (Table S4).
Decreased D-DT protein levels and mRNA
expression in adipose tissue from wound healing
disorders
To study the role of D-DT in the context of wound healing, D-DT
protein levels from HAT and IAT were measured by ELISA. Inflam-
matory adipose tissue showed significantly reduced D-DT levels
when compared to HAT (Fig. 1A). Simultaneously, D-DT mRNA
expression was analyzed by quantitative real-time PCR in order to
determine if attenuated D-DT protein levels were related to a
down-regulation of gene expression. Similar to the D-DT protein
levels, mRNA expression of D-DT was decreased in IAT when
compared with HAT (Fig. 1B). Immunohistochemical staining also
indicated a lower expression of D-DT protein in mature adipocytes
in IAT (Fig. 1C). Positive and negative controls can be found in
Figure S1.
Fig. 2 In vitro viability and proliferation assay of HDF. Viability and pro-
liferation were assessed for HDF cells. And for both assays, the cells
were incubated with supernatants from HAT and IAT supplemented with
varying concentrations of recombinant human D-DT for 24 hrs. (A) Via-
bility of HDF was measured by the alamarBlue assay after 24 hrs
stimulation with HAT or IAT supernatants supplemented with D-DT. Cell
viability increased in a dose-dependent manner, once cells were treated
with D-DT. Graphs represent mean  S.E.M., n= 14–16 from three
independent experiments; one-way ANOVA with Bonferroni’s multiple
comparison post-test. (B) HDF proliferation was analysed by the CytoS-
electTM assay after 24 hrs stimulation with HAT or IAT supernatants with
recombinant human D-DT. D-DT showed an induction of HDF prolifera-
tion in a dose-dependent manner. Graphs represent mean  S.E.M., n
=7 from two independent experiments; one-way ANOVA with Tukey’s mul-
tiple comparisons test (*P < 0.05, **P < 0.01, ***P < 0.001,
****P < 0.0001).
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D-DT levels do not correlate with the donor’s
body mass index
Given the reported positive correlation of MIF protein levels and the
BMI of HAT donor’s [4] and elevated MIF plasma levels in obese
patients [16], we also examined the correlation of D-DT levels with
the BMI of HAT donor patients and observed that unlike MIF [4],
D-DT did not correlate with the BMI of the donor in HAT (Spearman
r = 0.1664; Fig. S2).
D-DT increases the viability and proliferation of
HDF
To evaluate the role of D-DT in wound healing, we measured the
effect of D-DT on the viability and proliferation of HDFs. Human der-
mal fibroblasts incubated with supernatants from IAT showed signifi-
cantly decreased cell viability compared to HDF treated with
supernatants from HAT. However, once HDF were cultured with IAT
supernatants and treated with D-DT, the cell viability increased signifi-
cantly in a dose-dependent manner (Fig. 2A). We observed that D-DT
also induced HDF proliferation in a dose-dependent manner (Fig. 2B).
Increased wound healing in in vitro scratch
assay of HDF monolayers by D-DT and anti-MIF
We further used a standardized in vitro scratch assay that evaluates
the proliferation and migration of HDF from the wound edges. Mito-
mycin C was optionally added to eliminate the proliferation of HDF
and solely focus on the migration. Within the range of 50–200 ng/ml
recombinant D-DT, a trend towards increased wound healing was
detected, but a statistically significant dose-dependent effect was not
observed (Fig. 3A). When mitomycin C was added, the addition of D-
DT did not lead to an improved healing of HDF monolayers (Fig. 3C).
However, when neutralizing anti-MIF antibodies and recombinant
Fig. 3 In vitro scratch assay of HDF and supernatants from IAT and HAT. Wound healing of HDF monolayers was evaluated by an in vitro scratch
assay. Fibroblasts were incubated with supernatants of samples from IAT and HAT containing varying concentrations of recombinant human D-DT
and neutralizing MIF antibody. Medium containing 10% FCS served as a positive control and medium containing 0.5% FCS served as a negative
control. Experiments were performed in the absence and the presence of the proliferation inhibitor Mitomycin C. (A) Supernatants from IAT showed
no significant increase in proliferation and migration of fibroblasts when stimulated with D-DT alone. (B) When D-DT and anti-MIF were added
simultaneously, fibroblast proliferation and migration were increased significantly. (C and D) Fibroblast migration did not differ when Mitomycin C
was added. All measurements were normalized to the negative control, which was set as 1. Data are presented in relative migration distance of
fibroblasts  S.E.M. n = 8–12 from 3 independent experiments, one-way ANOVA with Tukey’s multiple comparisons test. Statistically significant dif-
ferences are indicated by asterisks (**P < 0.01, ***P < 0.001).
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D-DT were added simultaneously, the proliferation of HDF increased
significantly (Fig. 3B). These results suggest that D-DT may have an
opposing effect on wound repair which becomes apparent when MIF
is blocked, and that the process is primarily based on HDF prolifera-
tion rather than migration (Fig. 3D).
Differential expression of MIF and D-DT
receptors in human and murine adipose tissue
MIF and D-DT both bind and signal through the CD74/CD44 receptor
complex [15]. The chemokine receptors CXCR2 and CXCR4 also have
been described as receptors for MIF [24]. The mRNA expression of
CXCR2 and CXCR4 was up-regulated in human IAT (Fig. 4A and B)
and in mice a similar up-regulation in gene expression after LPS injec-
tion was observed for Cxcr2 in epididymal fat pads (Fig. 5A). How-
ever, the mRNA levels for Cxcr4 were not altered (Fig. 5B) in mouse
adipose tissue. Interestingly, expression of CD74 was down-regulated
in both human IAT (Fig. 4C) as well as in mouse adipose tissue
(Fig. 5C). Immunohistochemical staining of CXCR2, CXCR4 and
CD74 confirmed the results of the qPCR analysis and indicated an up-
regulation of CXCR2 and CXCR4 in IAT, whereas CD74 was down-
regulated (Fig. 4D–I). Finally, flow cytometry analysis of murine adi-
pose tissue revealed that the increase in CXCR2 and CXCR4, and the
decrease in CD74 primarily occurred in macrophages, whereas recep-
tor expression in adipocytes did not differ (Fig. 5D–I).
Decreased D-DT levels in mouse adipose tissue
after LPS stimulation
Mouse D-DT levels were measured in the epididymal fat pads one day
after injection of LPS into epididymal fat pads. D-DT levels decreased
in the LPS challenged group when compared to the PBS-injected
Fig. 4 Expression of the receptors CXCR2, CXCR4, and CD74 in human HAT and IAT samples. (A–C) RNA was isolated from HAT and IAT, Gene
expression for (A) CXCR2, (B) CXCR4 and (C) CD74 were determined and gene expression was analysed to GAPDH. CXCR2 and CXCR4 expression
was increased in human samples from IAT samples. The mRNA levels for CD74 showed a decrease in IAT samples. Data are presented as
mean  S.E.M., n = 12–16, two-tailed Student’s t-test. Statistically significant differences are indicated by asterisks (*P < 0.05). (D–I) Additionally,
immunohistological staining of HAT and IAT samples was performed.
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control group (Fig. 5A), recapitulating our observations in human
HAT and IAT.
D-DT exhibits decreased macrophage
recruitment into mouse adipose tissue after LPS
injection
To further elucidate the functional role of D-DT in IAT, we per-
formed an in vivo cell tracking experiment. Labelled PMs were
injected retro-orbitally into mice after induction of a local inflamma-
tory response in epididiymal fat pads by a combination injection of
LPS/MIF/D-DT. When compared to the control group (PBS injec-
tion), adipose tissue from LPS treated mice showed increased PM
invasion. Injection of LPS and MIF led to an increased PM accumu-
lation in the epididymal fat pads that was significantly higher than
in the LPS treated group. An increase in PM content was also
observed when D-DT was co-injected with LPS; however, this effect
was lower compared to MIF and did not reach statistical signifi-
cance (Fig. 6B).
Fig. 5 Expression of the receptors CXCR2, CXCR4, and CD74 in murine epididymal adipose tissue after PBS and LPS challenge. (A–C) RNA was iso-
lated from LPS challenged murine epididymal fat pads. PBS injected murine epididymal fat pads were used as control. Gene expression for (A)
Cxcr2, (B) Cxcr4 and (C) Cd74 were determined and gene expression was analysed to b-actin. After LPS challenge in epididymal fat tissue, Cxcr2
mRNA levels were increased in the adipose tissue, while Cxcr4 expression was unaltered. Cd74 expression was decreased after LPS injection. (D–I)
Recepter expression on adipocytes and ATM was studied by flow cytometry. (D–F) In adipocytes, receptor expression did not differ significantly.
(G–I) In ATM, by contrasts, CXCR2 and CXCR4 were significantly up-regulated in LPS injected fat pads, whereas CD74 was down-regulated. Data
are presented as mean  S.E.M., n = 5–5, two-tailed Student’s t-test. Statistically significant differences are indicated by asterisks (*P < 0.05).
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Discussion
In this study, we observed a decrease in D-DT expression at both the
protein and mRNA levels in IAT when compared to HAT. The first
study to describe D-DT as an adipokine was provided by Iwata et al.,
who showed that D-DT was mainly expressed in adipocytes and not
SVF cells [11]. Furthermore, the study showed that D-DT mRNA was
expressed during the course of adipogenic differentiation only in dif-
ferentiated adipocytes. Interestingly, in this study the mRNA expres-
sion of D-DT in adipocytes correlated negatively with the donor’s
BMI. Our study could not confirm a negative correlation of D-DT
levels with donor’s BMI; however, this may be attributed to the fact
that our study focused on the D-DT levels in entire subcutaneous adi-
pose tissue rather than only adipocyte-specific D-DT. These observa-
tions stand in contrast to MIF, which shows a positive correlation
with BMI and obesity, and has been shown to promote adipose tissue
inflammation [16, 25–27]. In our study, immunohistochemical stain-
ing revealed that in healthy tissue D-DT expression was overall dimin-
ished in the adipocytes of IAT when compared to controls. A recent
study showed that MIF is expressed in both adipocytes as well as SVF
cells and that within inflamed adipose tissue MIF mRNA expression
and protein levels were significantly increased [4]. These findings
point to potentially opposite functions of D-DT and MIF in adipose tis-
sue and wound repair.
Many studies have described wound healing to be impaired in
obese patients [9]. Favourable effects improving wound repair
involve keratinocyte and fibroblast migration, proliferation, differen-
tiation as well as keratinocyte and fibroblast interactions [28]. We
showed that supernatants from IAT had a harmful effect on the
viability of HDF. But when co-stimulated with D-DT, the harmful
effect of IAT supernatants was partially reversed and the cell via-
bility and proliferation increased in a D-DT dose-dependent man-
ner. These observations indicate that soluble factors from IAT
have detrimental effects on HDF cell viability and proliferation and
that the reduction of D-DT in IAT may play a role. D-DT alone did
not show significant effects on HDF in the scratch assay. The
simultaneous addition of MIF antibody, which was shown to have
beneficial effects on wound healing by impacting on fibroblast cell
migration [4], and recombinant D-DT, however, resulted in a sig-
nificant increase in HDF proliferation further suggesting that MIF
and D-DT may have opposing effects to fibroblast wound repair.
Although the exact mechanisms by which D-DT exerts its effects
are unknown, the activation of kinases such as the extracellular-
signal regulated kinases 1/2 may be a possibility [13].
Tissue resident macrophages can either arise from hematopoietic
or from embryonic progenitor cells and they fulfill tissue-specific
and niche-specific functions [29]. Previous studies report that during
obesity most adipose tissue resident macrophages originate from
infiltrating blood monocytes and some studies have suggested that
the migration and extension of macrophages in adipose tissue leads
to increased local inflammation, which in turn could impact wound
healing processes [30–32]. MIF and D-DT have been described to
inhibit the chemotaxis of peripheral monocytes [13]. When LPS was
injected into epididymal fat pads, D-DT protein levels were
decreased, similar to decreased D-DT levels in IAT. When murine
epididymal fat pads were challenged with LPS plus MIF or D-DT,
only LPS plus MIF led to a significant increase in invaded PM when
compared to the LPS treated group. Our data suggest that MIF may
be the more dominant factor in macrophage recruitment than D-DT.
Fig. 6 D-DT levels in LPS challenged mouse epididymal adipose tissue
and in vivo cell tracking of labelled peritoneal macrophages (PM). (A)
Murine epididymal fat pads were challenged by LPS injection and the
D-DT levels were measured by ELISA. D-DT levels in LPS challenged
epididymal fat pads were significantly diminished compared to the PBS
injected control group. Data are presented as mean  S.E.M., n = 6–7,
two-tailed Student’s t-test. (B) FITC-labelled peritoneal macrophages
were injected retro-orbitally into WT mice after inducing a local inflam-
mation in the epididiymal fat pads by LPS. Additionally, the fat pads
were also injected with recombinant MIF, D-DT and PBS as control.
After 48 hrs, mice were killed and FITC-positive macrophages were
measured by flow cytometry. Doublets were excluded by sideward scat-
ter (SSC) and forward scatter (FSC), macrophages were defined as
CD45, CD11b, and F4/80 positive cells. LPS injection led to an increase
of migrated PM when compared to PBS. The results also showed that
injection of LPS and MIF led to a higher PM accumulation in epididymal
fat pads compared to the injection of LPS only, whereas no such effect
was seen for LPS and D-DT. Data are presented as % of FITC-positive
PMs  S.E.M. n = 4–5 samples, from two independent experiments,
one-way ANOVA with Dunnett’s multiple comparisons test. Statistically
significant differences are indicated by asterisks (*P < 0.05,
***P < 0.001).
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Fig. 7 Schematic illustration of the function of D-DT and MIF in adipose tissue. Our data suggest that within healthy adipose tissue, D-DT may
increase the proliferation and vitality of human dermal fibroblasts. Upon inflammation the levels of D-DT decrease, while MIF expression is
enhanced, which subsequently may lead to an increase in peritoneal macrophage infiltration through MIF/CXCR4 or MIF/CXCR2 signalling, suggest-
ing a pathological role for MIF in adipose tissue.
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Presently, little is known about the expression of MIF/D-DT recep-
tors in adipose tissue and their association with adipose tissue
inflammation. Both MIF as well as D-DT bind to the cell surface recep-
tor CD74, but only MIF has been described to signal through the non-
cognate receptors CXCR2 and CXCR4 [15]. Our study showed an
increased expression of CXCR2 and CXCR4 in IAT, elevated levels of
CXCR2 in challenged mouse adipose tissue, while the expression of
CD74 was down-regulated in adipose tissue inflammation in both
humans and mice. Both CXCR2-mediated signalling, as well as
CXCR4-mediated signalling have been implicated with adipose macro-
phage and monocyte recruitment and the CD74/CD44 complex has
been shown to promote cell survival and pro-inflammatory responses
[15,24,33]. MIF expression was shown to be increased in human IAT,
and promoted macrophage infiltration to site of inflammation [4], cor-
relating with our data of increased CXCR2/CXCR4 expression in
human tissue. By flow cytometry we also showed that the up-regula-
tion of CXCR2 and CXCR4 is mainly found on macrophages, whereas
receptor expression on adipocytes was unaltered. Recent studies
have described the involvement of macrophage recruitment in acutely
inflamed adipose tissue, which occurred in combination with
decreased expression of intercellular adhesion molecule-1 and CD44,
two relevant adhesion molecules inducing monocyte infiltration
[4,27]. As CD74 needs CD44 for its beneficial functions (e.g. cell pro-
liferation), the observed decrease of CD44 expression is an indication
that CD74 also is not involved in this context; this correlates well with
the decrease in CD74 expression found in our study. Together with
the in vivo experiments, our results suggest that macrophage recruit-
ment into IAT is primarily promoted by MIF and CXCR2/4 rather than
through the D-DT-CD74 axis.
We have to acknowledge some limitations of the present work
which is an initial study to examine a role for D-DT during acute adi-
pose tissue inflammation and wound repair. First, the studies examin-
ing the effect of D-DT on HDF were performed in an in vitro setting in
an artificial environment and have to be interpreted with caution.
While the tissue expression of D-DT is low, high concentrations of
recombinant D-DT were necessary to see effects in the in vitro viabil-
ity, proliferation and wound healing assays. Definite conclusions can-
not be made until additional in vivo studies are performed. Second,
the LPS injection model used in our in vivo experiment is a simplified
model that does not mimic the more complex wound healing disor-
ders of the human samples. We also acknowledge that LPS was
injected into epididymal fat pads and not into subcutaneous adipose
tissue which may be a more appropriate tissue type.
Clearly, it would be interesting to further investigate the specific
function of D-DT in wound repair in more extended studies, for
example, using an in vivo wound model, preferably including an
adipose tissue conditional knockout of D-dt. Furthermore, in our
study we only have focused on whole adipose tissue without differ-
entiation of the respective cell fractions. Therefore, it may be inter-
esting to investigate changes in MIF, D-DT, and receptor
expression after separation into adipose tissue (e.g. after collage-
nase digestion) in future studies.
In conclusion, our study indicates that D-DT may play a dis-
tinct role from MIF in adipose tissue inflammation during wound
healing disorders. In contrast to MIF, D-DT protein and mRNA
levels were decreased in IAT, which may be detrimental for wound
healing since supplementation with recombinant D-DT led to sig-
nificantly increased HDF viability and proliferation. Furthermore,
our data suggest that in contrast to D-DT, MIF is the more potent
chemokine that facilitates the recruitment of macrophages to the
inflammatory site by its receptors CXCR2/4. A schematic illustra-
tion of our findings and the reciprocal roles of MIF and D-DT in
adipose tissue is demonstrated in Figure 7. However, additional
in vivo studies are required especially to draw a final conclusion
regarding the effect of D-DT on fibroblasts as the in vitro studies
show several major limitations.
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